Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agios Pharmaceuticals (AGIO) Receivables - Other: 2013-2024

Historic Receivables - Other for Agios Pharmaceuticals (AGIO) over the last 9 years, with Dec 2024 value amounting to $4.1 million.

  • Agios Pharmaceuticals' Receivables - Other rose 61.29% to $5.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.0 million, marking a year-over-year increase of 61.29%. This contributed to the annual value of $4.1 million for FY2024, which is 46.23% up from last year.
  • Agios Pharmaceuticals' Receivables - Other amounted to $4.1 million in FY2024, which was up 46.23% from $2.8 million recorded in FY2023.
  • In the past 5 years, Agios Pharmaceuticals' Receivables - Other ranged from a high of $4.1 million in FY2024 and a low of $2.2 million during FY2022.
  • Its 3-year average for Receivables - Other is $3.0 million, with a median of $2.8 million in 2023.
  • Data for Agios Pharmaceuticals' Receivables - Other shows a peak YoY surged of 46.23% (in 2024) over the last 5 years.
  • Agios Pharmaceuticals' Receivables - Other (Yearly) stood at $2.2 million in 2022, then grew by 27.38% to $2.8 million in 2023, then surged by 46.23% to $4.1 million in 2024.